Vice President of Regulatory Affairs
United States of America
David Quiggle was appointed Vice President, Regulatory Affairs, for Amerigen in October 2015. Mr. Quiggle has 20 years of pharmaceutical experience, with a focus on generic product development. Prior to joining Amerigen, he was Senior Director, Regulatory Affairs, at Anchen Pharmaceuticals (part of Par Pharmaceuticals). Prior to that, Mr. Quiggle held positions at Watson Laboratories (now Actavis Inc.) and Encore Pharmaceuticals. He also worked at Loma Linda University in the School of Medicine performing preclinical drug development.
Mr. Quiggle received his Bachelors of Science and Masters of Science in Biology from the California State University.